Congenital cholestatic syndromes: what happens when children grow up?

S C Ling1

  • 1Department of Gastroenterolgy, The Hospital for Sick Children, Toronto, Canada. simon.ling@sickkids.ca

Insights

Congenital cholestasis in adults presents a spectrum of liver disease severity, from cirrhosis to mild forms. Management involves addressing complications like portal hypertension and nutritional deficiencies, with liver transplantation as a key option.

Area of Science:

  • Hepatology
  • Pediatric Gastroenterology
  • Internal Medicine

Background:

  • Congenital cholestasis, though rare in adult practice, affects individuals surviving into adulthood with native livers.
  • Common conditions include biliary atresia, Alagille syndrome, Caroli disease, and progressive familial intrahepatic cholestasis.
  • Outcomes into adulthood reveal a wide spectrum of liver disease severity.

Purpose of the Study:

  • To review the adult outcomes of four congenital cholestatic syndromes.
  • To highlight common complications and indications for liver transplantation.
  • To emphasize the need for improved understanding of biliary physiology.

Main Methods:

  • Review of published data on adult outcomes of congenital cholestatic syndromes.
  • Analysis of disease spectrum, complications, and treatment indications.
  • Discussion of associated features and potential therapeutic advancements.

Main Results:

  • Adults with biliary atresia often develop cirrhosis without transplantation.
  • Mild or subclinical disease can occur, as seen in Alagille syndrome carriers.
  • Portal hypertension and nutritional deficiencies are frequent complications.

Conclusions:

  • Congenital cholestatic syndromes present diverse adult liver disease manifestations.
  • Management requires addressing complications and considering liver transplantation.
  • Further research into biliary physiology is crucial for improved therapies.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Jaundice01:25

Jaundice

Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...